SGLT-2 inhibitors in development for type 2 diabetes treatment
about
Cardiovascular effects of antidiabetic agents: focus on blood pressure effects of incretin-based therapiesSodium-Glucose linked transporter 2 (SGLT2) inhibitors--fighting diabetes from a new perspective.Carcinogenicity risk assessment supports the chronic safety of dapagliflozin, an inhibitor of sodium-glucose co-transporter 2, in the treatment of type 2 diabetes mellitus.A Review on the Relationship between SGLT2 Inhibitors and Cancer.Ipragliflozin: A novel sodium-glucose cotransporter 2 inhibitor developed in Japan.The continuing need for drug development and clinical trials in type 2 diabetes and its complications: introduction to the RDS special issue.The vascular endothelium in diabetes--a therapeutic target?Emerging sodium/glucose co-transporter 2 inhibitors for type 2 diabetes.The central question of type 2 diabetes.Efficacy and safety of canagliflozin in type 2 diabetes mellitus: systematic review of randomized controlled trials.
P2860
Q26866958-E84DA691-89FD-47B3-B871-48A8DA57F6AAQ30833760-4A4B67CE-9AA2-4073-9F34-47E2BF0D7AD2Q33785128-A747F052-7FAC-4B74-8B05-E48441C86D0EQ34181385-A7F2F25E-8AFF-4B9E-8866-E049104406DEQ35049845-7DC5D3B1-7FAF-4213-A29B-D1C8E6F24B19Q35760275-2D6F47B5-5B8A-4B9C-8524-94B291EB7C12Q36673550-91502F7B-07DF-49A7-B071-997BD5881117Q38130748-B9B31508-514D-4B21-A4B9-69ED0CCB9303Q38162978-29E7CE26-8A30-4482-9B01-7F43EA701B62Q38663903-2C164530-9AAD-4D2F-BEDE-50B0E932D1AD
P2860
SGLT-2 inhibitors in development for type 2 diabetes treatment
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
SGLT-2 inhibitors in development for type 2 diabetes treatment
@ast
SGLT-2 inhibitors in development for type 2 diabetes treatment
@en
SGLT-2 inhibitors in development for type 2 diabetes treatment
@nl
type
label
SGLT-2 inhibitors in development for type 2 diabetes treatment
@ast
SGLT-2 inhibitors in development for type 2 diabetes treatment
@en
SGLT-2 inhibitors in development for type 2 diabetes treatment
@nl
prefLabel
SGLT-2 inhibitors in development for type 2 diabetes treatment
@ast
SGLT-2 inhibitors in development for type 2 diabetes treatment
@en
SGLT-2 inhibitors in development for type 2 diabetes treatment
@nl
P2093
P2860
P356
P1476
SGLT-2 inhibitors in development for type 2 diabetes treatment
@en
P2093
Abd A Tahrani
Anthony H Barnett
Mithun Bhartia
P2860
P304
P356
10.1900/RDS.2011.8.348
P577
2011-11-10T00:00:00Z